Abstract
Background: Rapid Lateral Flow Test (LFT) has been broadly utilized in detection or diagnosis of numerous disease-related antigens and antibodies. It is the most popular format of point-of-care test (POCT) and quickest and easiest way to detect a targeted molecule. In the combat against COVID-19 pandemic, hundreds of POCTs have been developed and are commercially available now. They are designed to detect either a SARS-CoV-2 viral antigen or IgG and IgM antibodies binding to it. Among the binding antibodies, a special type of functional antibodies that block the interaction between SARS-CoV-2 virus and its human receptor, neutralizing antibodies (NAbs), are of particular interest to public as well as in vaccination management. However as of today, POCTs for the detection of SARS-CoV-2 NAbs remain under late stage of development. Scope and method: In this review, we first summarize the importance of awareness and monitoring of SARS-CoV-2 NAbs in the combat against COVID-19 pandemic. Secondly, we compare the available methods for the detection of SARS-CoV-2 NAbs. Next, we describe challenges in the development of a rapid lateral flow test for the detection of SARS-CoV-2 NAbs. Finally, we outline its product formats and applications in research and in disease management. Conclusion: Vaccine effectiveness is unknown for an individual unless measured. NAb level is the most viable measurement for vaccine effectiveness or immunity. A broadly accessible NAb POCT is urgently needed.
Keywords: Lateral flow test; SARS-CoV-2; diagnostics; neutralizing antibodies; point-of-care.
【저자키워드】 SARS-CoV-2, Neutralizing antibodies, diagnostics, point-of-care, Lateral flow test, 【초록키워드】 neutralizing antibody, antibodies, Vaccine, vaccination, Immunity, Neutralizing antibodies, antibody, COVID-19 pandemic, Test, Diagnosis, SARS-CoV-2 virus, Antigen, point-of-care, Viral, Lateral flow test, IgM antibodies, management, Research, POCT, Effectiveness, Awareness, Rapid, antigens, Neutralizing, receptor, binding antibodies, disease, binding, Interaction, Flow, IgG and IgM, Viral antigen, individual, NAbs, today, late stage, combat, antibodies binding, SARS-CoV-2 nAbs, SARS-CoV-2 viral, detect, functional, Lateral, SARS-CoV-2 NAb, 【제목키워드】 Rapid, SARS-CoV-2 neutralizing antibody,